Filtering by:
Liver CancerFacts & Figures 2018: Rate of Deaths From Cancer Continues Decline
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.
FDA Approves Opdivo (Nivolumab) for Liver Cancer
The US Food and Drug Administration (FDA) has approved Opdivo (nivolumab), a monoclonal antibody, which is a type of immunotherapy, to treat liver cancer.
FDA Approves Stivarga (Regorafenib) for Liver Cancer
The US Food and Drug Administration (FDA) has expanded the approved use of the targeted therapy drug Stivarga (regorafenib) to treat liver cancer.
Annual Report to the Nation: Cancer Death Rates Continue to Drop
The death rate from cancer in the United States is continuing to decline among men, women, and children, according to the latest Annual Report to the Nation on the Status of Cancer.
Most Baby Boomers Not Getting Recommended Test for Hepatitis C
American Cancer Society researchers report that most baby boomers, those born between 1945 and 1965, have not been tested for the hepatitis C virus (HCV). People infected with HCV are at greater risk for liver diseases, including liver cancer.
Cancer Death Rates Vary Greatly Among US Counties
Researchers in Seattle analyzed the death rate from 29 cancer types in every county in the United States between 1980 and 2014.
CDC: 40% of Cancer Cases in US Might Be Linked to Tobacco
New data from the Centers for Disease Control and Prevention (CDC) show that 40% of cancers diagnosed in the US may have a link to tobacco use.
World Health Organization Links 8 More Cancer Types to Excess Weight
The International Agency for Research on Cancer (IARC), part of the World Health Organization, has added 8 types of cancer to those it had previously linked to being overweight or obese.